CDNA
HOLD / NEUTRALNeutralComposite
62.20
Technical
97.60
Fundamental
38.60
Rank
—
Price
50.80
Hurst
0.48
As of
Aug 26, 2026
Daily
CareDx, Inc.
HealthcareDiagnostics & ResearchCareDx develops and provides diagnostic and monitoring solutions for transplant patients across multiple organ types including kidney, heart, and lung. The company's product portfolio includes blood-based tests that detect donor-derived DNA to assess organ health, tissue biopsy analysis, HLA typing for transplant compatibility, patient management software, and solutions for monitoring cell therapy recipients. CareDx also offers diagnostic tools for non-transplant conditions such as leukemia relapse prediction.
Market cap
$2.8B
P/E (trailing)
25.73
P/E (forward)
40.86
PEG ratio
—
Dividend yield
—
Beta
2.43
52w range
13.95 – 55.16
Return on equity
+29.49%
Profit margin
+24.23%
Revenue growth
+52.20%
Earnings growth
—
Price history
1Y: 54.28 (+267.5%) · range 14.28–54.28
Cycle position
77/ 100 cycle scoreEXIT ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 4 · NOT READY · exit proximity 35
Conviction
21/ 100 · maturity 29%
VScore.1613
Buildup.2833
EMA entry setup.354
Fundamentals.2139
Volume profile
POC
21.50
Price vs POC
+152.5%
Overhead supply
0%
Runway
open sky
Value area 15.56–45.66 · 0% of 120d volume overhead · clean runway
Contributing sources
No source detections in the last 21 days.
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -1.37% | +2.75% | 11/20d |
| 40d | -1.37% | +2.75% | 11/40d |